Tag: health care industry

April 18, 2026

Hims Peptides: Driving Revenue Growth Ahead of 2026 FDA Review

April 16, 2026

CDC Leadership Turmoil Under HHS Secretary RFK Jr.

April 13, 2026

Revolution Medicines’ Pancreatic Cancer Drug Hits Phase 3 Trial Goal

April 7, 2026

Trump Administration to Increase Medicare Advantage Payments by $13 Billion in 2027

March 8, 2026

FDA Official to Exit Amid Drug Approval Concerns & Industry Criticism

March 7, 2026

Wellness Clubs Boom as People Seek ‘Third Spaces’ to Combat Loneliness

February 8, 2026

Hims & Hers Pulls Copycat Wegovy Pill Amid Legal Threats & FDA Action

February 6, 2026

Trump Launches TrumpRx: Will New Website Lower Drug Costs?

February 5, 2026

Lilly Outpaces Novo Nordisk in Obesity Drug Market: 2026 Outlook

February 4, 2026

Eli Lilly Blows Past Estimates as Zepbound & Mounjaro Demand Soars

January 17, 2026

Novo Nordisk Shares Rise: Wegovy Obesity Pill Launch Success

January 16, 2026

Trump Health Care Plan Congress ACA Subsidies

January 10, 2026

Obesity Pills 2026: Novo Nordisk & Eli Lilly Lead the Way

January 9, 2026

Abivax Stock Surge: Biotech Takeover Target

January 1, 2026

UnitedHealth Group Audit Results Released

December 30, 2025

Trump’s 2025 Wall Street Deals: Tariffs & Uncertainty Slow M&A